Not finding it? Sign in to also search OpenAlex live.
-
Classical Mathematical Models for Prediction of Response to Chemotherapy and Immunotherapy2021 bioRxiv (Cold Spring Harbor Laboratory) preprint Mathematics Mathematical Biology Tumor Growth Open access
Narmin Ghaffari Laleh, Chiara Maria Lavinia Loeffler, Julia Grajek, Kateřina Staňková, Alexander T. Pearson, Hannah Sophie Muti, +4 more
14citations -
Imaging of Response to Radiosurgery and Immunotherapy in Brain Metastases: Quo Vadis?2021 Current Treatment Options in Neurology article Medicine Brain Metastases and Treatment Open access
Norbert Galldiks, Jan‐Michael Werner, Philipp Lohmann, Martin Köcher, Gereon R. Fink, Karl‐Josef Langen
1citations -
Facts and Hopes on the Use of Artificial Intelligence for Predictive Immunotherapy Biomarkers in Cancer2022 Clinical Cancer Research article Medicine Radiomics and Machine Learning in Medical Imaging Open access
Narmin Ghaffari Laleh, Marta Ligero, Raquel Pérez-López, Jakob Nikolas Kather
57citations -
Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer2021 Journal of Translational Medicine article Medicine PARP inhibition in cancer therapy Open access cited by 1 patent
Jinyu Meng, Jin Peng, Jie Feng, Jochen Maurer, Xiao Li, Yan Li, +11 more
63citations -
1028P BIOLUMA: A phase II trial of nivolumab in combination with ipilimumab to evaluate efficacy and safety in lung cancer and to evaluate biomarkers predictive for response – results from the NSCLC cohort
Rieke Nila Fischer, Julie George, Andreas Hans Scheel, Hans Anton Schloesser, Peter Brossart, W. Engel-Riedel, +14 more
1citations -
Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapy2024 Journal of Experimental & Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Extracellular vesicles in disease Open access
Joao Gorgulho, Sven Heiko Loosen, Ramsha Masood, Franziska Giehren, Francesca Pagani, Gustav Buescher, +26 more
12citations -
Data from Human Renal Cancer Cells Express a Novel Membrane-Bound Interleukin-15 that Induces, in Response to the Soluble Interleukin-15 Receptor α Chain, Epithelial-to-Mesenchymal Transition
Krystel Khawam, Julien Giron‐Michel, Yanhong Gu, Aurélie Perier, Anne Caignard, Aurore Devocelle, +6 more
0citations -
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors2025 UTUPub (University of Turku) article Medicine Cytomegalovirus and herpesvirus research Open access
Bonifacius A, Britta Lamottke, Sabine Tischer‐Zimmermann, Rebecca Schultze-Florey, Lilia Goudeva, Heuft Hg, +31 more
0citations -
Data from Human Renal Cancer Cells Express a Novel Membrane-Bound Interleukin-15 that Induces, in Response to the Soluble Interleukin-15 Receptor α Chain, Epithelial-to-Mesenchymal Transition
Krystel Khawam, Julien Giron‐Michel, Yanhong Gu, Aurélie Perier, Anne Caignard, Aurore Devocelle, +6 more
0citations -
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors2023 Journal of Clinical Investigation article Medicine Cytomegalovirus and herpesvirus research Open access
Agnes Bonifacius, Britta Lamottke, Sabine Tischer‐Zimmermann, Rebecca Schultze-Florey, Lilia Goudeva, Hans‐Gert Heuft, +30 more
44citations -
Glutamic acid decarboxylase antibody-associated neurological syndromes: Clinical and antibody characteristics and therapy response2022 Journal of the Neurological Sciences article Medicine Autoimmune Neurological Disorders and Treatments
Marie Madlener, Christine Strippel, Franziska Thaler, Kathrin Doppler, K.-P. Wandinger, Jan Lewerenz, +26 more
24citations -
Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer
Bruno Valentin Sinn, Sibylle Loibl, Claus Alexander Hanusch, Dirk-Michael Zahm, Hans‐Peter Sinn, Michael Untch, +16 more
46citations -
Abstract PD5-08: Tumor immune-cell activity assessed by RNAseq is an independent predictor of therapy response and prognosis after neoadjuvant chemotherapy in HER2 negative breast cancer patients - An analysis of the GeparSepto trial2020 Cancer Research conference-abstract Medicine Cancer Immunotherapy and Biomarkers cited by 1 patent
Peter Andreas Fasching, Carsten Denkert, Stephen Charles Benz, Karsten Ernst Weber, Christopher W. Szeto, Jan Budczies, +17 more
1citations